Document and Entity Information
Document and Entity Information | Dec. 13, 2023 |
Document Information [Line Items] | |
Document Type | 8-K |
Document Period End Date | Dec. 13, 2023 |
Entity Registrant Name | NEUROGENE INC. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-36327 |
Entity Tax Identification Number | 98-0542593 |
Entity Address Address Line 1 | 535 W 24th Street |
Entity Address Address Line 2 | 5th Floor |
Entity Address City Or Town | New York |
Entity Address State Or Province | NY |
Entity Address Postal Zip Code | 10011 |
City Area Code | 877 |
Local Phone Number | 237-5020 |
Entity Information Former Legal Or Registered Name | Neoleukin Therapeutics, Inc. |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.000001 per share |
Trading Symbol | NGNE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Current Fiscal Year End Date | --12-31 |
Entity Central Index Key | 0001404644 |
Amendment Flag | false |
Former Address [Member] | |
Document Information [Line Items] | |
Entity Address Address Line 1 | 188 East Blaine Street |
Entity Address Address Line 2 | Suite 450 |
Entity Address City Or Town | Seattle |
Entity Address State Or Province | WA |
Entity Address Postal Zip Code | 98102 |